- Representing Lek Pharmaceuticals d.d. and Sandoz Inc. in a patent infringement action relating to the drug ibrutinib (Imbruvica®). Pharmacyclics LLC, et al. v. Zydus Worldwide DMCC, et al., No. 1:18-cv-00275 (D. Del.).
- Represented Hubei Grand Life Science and Technology Co. Ltd. in an IPR proceeding which resulted in all challenged claims being found unpatentable. Hubei Grand Life Science and Technology Co. Ltd. v. Vitaworks IP LLC, IPR No. 2018-01766.
Associate,
- Phone: 212.210.1287
- Email: maddy.byrd@alston.com
Given her extensive research experience, Maddy is able to comprehend the more technical aspects of her clients’ needs, while still using her attention to detail to efficiently address complex legal issues.